Ocular drug delivery has constantly challenged ophthalmologists and drug delivery
scientists due to various anatomical and physiological barriers. Static and dynamic ocular …

Ophthalmic drugs used for the treatment of various ocular diseases are commonly
administered by eye drops. However, due to anatomical and physiological factors, there is a …

Ophthalmic diseases represent a significant problem as over 2 billion people worldwide
suffer from vison impairment and blindness. Eye drops account for around 90% of …

Enabling non-invasive delivery of proteins across the mucosal barriers promises improved
patient compliance and therapeutic efficacies. Cell-penetrating peptides (CPPs) are …

This review highlights the application of lipid nanoparticles (Solid Lipid Nanoparticles,
Nanostructured Lipid Carriers, or Lipid Drug Conjugates) as effective drug carriers for …

Posterior segment diseases, such as age-related macular degeneration (AMD) and diabetic
retinopathy (DR) are vital factor that seriously threatens human vision health and quality of …

Ocular posterior segment diseases such as uveitis, X-linked juvenile retinoschisis, or age-
related macular degeneration usually result in progressive and irreversible vision loss …

Metabolic reprogramming is a common hallmark of cancer cells. Cancer cells exhibit
metabolic flexibility to maintain high proliferation and survival rates. In other words …

Introduction Research on nanotechnology in medicine has also involved the ocular field and
nanomicelles are among the applications developed. This approach is used to increase …

The eye is a complex structure with a variety of anatomical barriers and clearance
mechanisms, so the provision of safe and effective ophthalmic drug delivery technology is a …